论文部分内容阅读
目的探讨利用经皮中心静脉导管微创引流控制胸腔积液的效果及优点。方法 66例经皮中心静脉导管微创引流患者为研究组,同期48例常规胸腔穿刺抽液患者为对照组,对两组患者的胸腔积液控制时间、平均住院日、穿刺次数、专项治疗费用及穿刺不良事件等方面进行观察和比较。结果研究组的人均胸腔穿刺次数、胸腔积液消失天数、平均住院天数、专项治疗费用及人均穿刺不良事件发生率分别为1.11次、(4.0±2.6)d、(9.6±3.0)d、(256±45)元和12.1%,对照组分别为4.08次、(8.9±3.1)d、(15.7±4.2)d、(432±57)元和31.3%,两组比较差异均有统计学意义(P<0.01或0.05)。结论经中心静脉导管微创引流是控制胸腔积液简便经济且创伤小的有效方法,值得临床推广。
Objective To explore the effect and advantages of percutaneous central venous catheter minimally invasive drainage in the control of pleural effusion. Methods 66 patients with minimally invasive percutaneous central venous catheter drainage for the study group, the same period 48 cases of conventional pleural fluid as control group, the two groups of patients with pleural effusion control time, the average length of stay, the number of punctures, special treatment costs And puncture adverse events and other aspects of observation and comparison. Results The incidence of thoracentesis, days of disappearance of pleural effusion, days of hospitalization, special treatment and per capita puncture adverse events in the study group were 1.11, 4.0 ± 2.6 d, 9.6 ± 3.0 d and 256 respectively ± 45) yuan and 12.1% in control group were 4.08 times (8.9 ± 3.1) d, (15.7 ± 4.2) days, (432 ± 57) yuan and 31.3%, respectively, with significant difference between the two groups <0.01 or 0.05). Conclusion Minimally invasive drainage through central venous catheter is an effective and economical method to control pleural effusion, which is worthy of clinical promotion.